In October,
the EU opened up a consultation process to review the implementation of Horizon
2020, the European Healthcare R+D programme. Salud por Derecho has closely
followed the process with a two-fold strategy: on the one hand, to advocate
throughout the EU for our viewpoint and, on the other hand, to introduce said
process to the Spanish scientific community.
The result has been participation in two drafting processes: the first with EU civil society - HAI, MSF, GHA, UAEM and Bukopharma – preparing a document with key recommendations, as approved by the majority of the Alliance members. And the second, the Salud por Derecho position jointly developed along with Spanish researchers and experts to gather their opinions and viewpoints, enriching the document and obtaining a commitment from the community. This is our position document. |
MOBILISATION AND
IMPACT ON ACCESS TO R+D
High-Level United Nations Panel on Access to Medications
|
Spanish Medical Association roundtable
|
ENVI
|
TTIP leaks
|
Horizon 2020
|
UCM Access to Medication Conference
|
Access to Medicines and Innovation
|
Healthy innovation for all
|
European Alliance for responsible research and affordable medicines
|
EACH Group
|
EPHA Group on Access to Medicines
|
Global Health Policy Forum
|
Hepatitis C
|